CMS certification 050573
Eisenhower Medical Center
39-000 Bob Hope Drive, Rancho Mirage, CA 92270
Eisenhower Medical Center has a CMS overall rating of 4 out of 5 stars. 78% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 9 and worse on none. Emergency patients spend a median of 4 h 19 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 3,489 completed surveys, 27% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | CA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 365 visits sampled · US median for EDs of the same volume: 3 h 21 min | 4 h 19 min | 2 h 54 min | 2 h 42 min |
| Left before being seen Lower is better · 98,274 patients | 0% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 30 patients | 30% | 74% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 128 patients | 62% | 70% | 65% |
How Eisenhower Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Eisenhower Medical CenterThis hospital | 4/5 | 78% | 4 h 19 min | 9 better |
| Desert Regional Medical CenterSame county · Palm Springs | 2/5 | 62% | 2 h 58 min | 1 better 2 worse |
| San Gorgonio Memorial HospitalSame county · Banning | 3/5 | 68% | 3 h 14 min | 1 better |
| John F Kennedy Memorial HospitalSame county · Indio | 2/5 | 53% | 2 h 24 min | 1 better |
| Riverside Community HospitalSame county · Riverside | 2/5 | 64% | 3 h 9 min | 3 better 4 worse |
| Parkview Community Hospital Medical CenterSame county · Riverside | 3/5 | 64% | 2 h 52 min | 1 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 7,103 cases | Too few cases | 4.8% | 3.9% |
| Heart attack 371 cases | Too few cases | 11.8% | 11.9% |
| Heart failure 831 cases | Too few cases | 12.5% | 11.1% |
| Pneumonia 1,069 cases | Too few cases | 16.4% | 15.2% |
| Stroke 542 cases | Too few cases | 16.3% | 11.9% |
| COPD 202 cases | Too few cases | 10.3% | 8.6% |
| Heart bypass surgery (CABG) 132 cases | Too few cases | 1.8% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Better | 0.74 likely 0.51 – 0.97 | 1 |
| After hip or knee replacement 530 cases | Too few cases | 3.4% | 4.1% |
| Deaths after a serious but treatable surgical complication 150 cases | No different | 144.87 per 1,000 likely 102.6 per 1,000 – 187.13 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 10,736 cases | Better | 0.09 per 1,000 likely 0 per 1,000 – 0.62 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 14,622 cases | No different | 0.31 per 1,000 likely 0.13 per 1,000 – 0.49 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 15,563 cases | No different | 0.31 per 1,000 likely 0.14 per 1,000 – 0.48 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 4,469 cases | No different | 2.28 per 1,000 likely 1.11 per 1,000 – 3.45 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 2,294 cases | No different | 1.19 per 1,000 likely 0 per 1,000 – 2.48 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 2,258 cases | No different | 8.26 per 1,000 likely 4.04 per 1,000 – 12.48 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 4,726 cases | No different | 2.23 per 1,000 likely 0.7 per 1,000 – 3.77 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 2,297 cases | No different | 4.78 per 1,000 likely 2.02 per 1,000 – 7.53 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,029 cases | No different | 1.78 per 1,000 likely 0.37 per 1,000 – 3.18 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,062 cases | No different | 1.01 per 1,000 likely 0.22 per 1,000 – 1.8 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.23 likely 0.07 – 0.56 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.27 likely 0.11 – 0.56 | 1 |
| Surgical site infections after colon surgery | No different | 0.94 likely 0.46 – 1.72 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.54 likely 0.03 – 2.68 | 1 |
| MRSA bloodstream infections | No different | 0.68 likely 0.22 – 1.64 | 1 |
| C. diff intestinal infections | Better | 0.21 likely 0.1 – 0.39 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 582 cases | Too few cases | 13.8% | 14.4% |
| Readmitted after heart failure 1,067 cases | Too few cases | 20.2% | 21.3% |
| Readmitted after pneumonia 1,336 cases | Too few cases | 17% | 17.3% |
| Readmitted after COPD 311 cases | Too few cases | 18.3% | 20% |
| Readmitted after heart bypass surgery 139 cases | Too few cases | 10.6% | 11% |
| Readmitted after hip or knee replacement 514 cases | Too few cases | 4.6% | 5.8% |
| Days back in hospital after a heart attack 427 cases | Too few cases | -2.4 days per 100 | — |
| Days back in hospital after heart failure 980 cases | Too few cases | -2.4 days per 100 | — |
| Days back in hospital after pneumonia 1,156 cases | Too few cases | -6.2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,233 cases | Better | 9.5 per 1,000 likely 7.6 per 1,000 – 11.9 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 899 cases | No different | 10.7 per 100 likely 8.9 per 100 – 12.7 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 899 cases | No different | 5.8 per 100 likely 4.6 per 100 – 7.2 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 3,289 cases | Better | 0.6 likely 0.5 – 0.8 | — |
1 more measure had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $778,338
- 2020 $740,540
- 2021 $593,652
- 2022 $730,994
- 2023 $996,978
- 2024 $1.3M
- 2025 $1.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $346,000 | 5 |
| Speaking, teaching and other services | $22,900 | 26 |
| Consulting fees | $20,000 | 4 |
| Medical devices and supplies on long-term loan | $5,699 | 4 |
| Debt forgiveness | $4,142 | 3 |
| Space rental and facility fees | $599 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Research & Development, LLC | $247,126 | 58 |
| Novo Nordisk AS | $216,000 | 1 |
| Edwards Lifesciences Corporation | $156,318 | 25 |
| Takeda Pharmaceuticals U.S.A., Inc. | $130,000 | 4 |
| Regeneron Pharmaceuticals, Inc. | $90,590 | 18 |
| Argenx US, INC. | $54,248 | 24 |
| Abbvie INC. | $28,425 | 9 |
| AstraZeneca Pharmaceuticals LP | $26,285 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral … Janssen Research & Development, LLC | $222,052 |
| The PROGRESS Trial 2021-01 Edwards Lifesciences Corporation | $110,899 |
| A PHASE 3 STUDY OF FIXED DOSE COMBINATIONS OF FIANLIMAB AND CEMIPLIMAB VERSUS RELATLIMAB AND NIVOLUMAB IN PARTICIPANTS WITH UNRESECTABLE OR METASTATI… Regeneron Pharmaceuticals, Inc. · NCT06246916 | $90,590 |
| Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients W… ARGENX US, INC. | $31,619 |
| A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With P… ABBVIE INC. · NCT04928846 | $27,825 |
| A Multicenter,Single arm,Open label,Post Authorization,Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants wit… AstraZeneca Pharmaceuticals LP | $26,285 |
| A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial Fibrillation for Anticoagula… Janssen Research & Development, LLC | $25,074 |
| A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficac… ARGENX US, INC. | $22,629 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Eisenhower Medical Center
Is Eisenhower Medical Center a good hospital?
Eisenhower Medical Center has a CMS overall rating of 4 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 9 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Eisenhower Medical Center?
78% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 3,489 completed HCAHPS surveys.
How long is the wait in the Eisenhower Medical Center emergency room?
Emergency patients spend a median of 4 h 19 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 0% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Eisenhower Medical Center receive money from drug and device companies?
Drug and device makers reported $1.1M in payments to Eisenhower Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.